Schizophrenia is a terribly disabling mental health problem with its victims exhibiting symptoms like deficiencies in balanced thought process, distortion in understanding and emotions, and delusions. For patients of schizophrenia, physicians usually recommend a combination of medicines and behavioral therapies, but lack of efficiency in these treatment options usually results in a relapse.
To tackle this problem and help patients of schizophrenia seeking prolonged exoneration from the symptoms of the disorder, a recent study has suggested Rexulti, a serotonin-dopamine activity modulator
The findings of the study, titled “Effect of brexpiprazole on long-term remission in adults with schizophrenia: Results of an open-label, long-term study,” were presented at the Psych Congress held in New Orleans in September 2017.
Commenting on the findings, Dr. Ruth Duffy, medical director of Otsuka Pharmaceutical Development and Commercialization, said, “The analysis showed that, in addition to showing efficacy and tolerability in treating acute exacerbation of schizophrenia, Rexulti patients receiving 2 mg and 4 mg per day showed sustained long-term remission over greater than one year.”
Prevalence of schizophrenia
According to the National Alliance on Mental Illness (NAMI), 1.1 percent adult Americans live with schizophrenia during any given year. Schizophrenia can affect anyone irrespective of their race, gender, age and social standing. Though there is no particular age at which the signs of schizophrenia may be diagnosed, experts say that adolescent males are more prone to suffer from this disorder. In comparison, females are more vulnerable to exhibit manifestations of the disease around 25-30 years, and then again after 40.
Family members handling patients of schizophrenia often complain that though medications help in alleviating the level of psychosis or suppressing delusions, the side effects of some of these drugs can be severe. Behavioral interventions help calm down, though there is always a fear of relapse. Physicians are not clear about the factors that cause the disorder to develop and exacerbate. However, studies have revealed a potential interaction between genes and environmental conditions that may cause some people to be afflicted with schizophrenia. The common symptoms of schizophrenia include:
Seeking treatment for schizophrenia
According to the World Health Organization (WHO), schizophrenia affects nearly 21 million people all over the world. People with schizophrenic are 2-2.5 times more likely to die early than the normal public, often due to cardiovascular and infectious diseases. Besides, schizophrenia is linked to considerable disability and can affect occupational and educational performance.
It takes time to get rid of schizophrenia. Moreover, complete recovery from any kind of mental illness is possible only with timely treatment and most people tend to avoid this due to fear of stigma and backlash. A leader among the nation’s schizophrenia treatment centers, Sovereign Health of Florida offers evidence-based behavioral treatment programs for both men and women affected by mental illnesses, including schizophrenia. The treatment of schizophrenia at our state-of-the-art facilities comprises a combination of medications, psychotherapy, alternative therapies and counseling. For more information on our holistic mental health treatment programs or to locate our advanced schizophrenia rehabilitation centers near you, call our 24/7 helpline number. You can even chat online with our representatives for further assistance.
Get the latest news on program developments, behavioral health news and company announcements